Stan Kurowski

Discovery of a Novel, Orally Active Himbacine-Based Thrombin Receptor Antagonist (SCH 530348) with Potent Antiplatelet Activity

Samuel Chackalamannil, Yuguang Wang, William J. Greenlee et al. · Journal of Medicinal Chemistry · 2008 · 267 citations · Full text

Immunology, Cardiovascular Pharmacology, Pharmacotherapy +21

SCH 602539, a Protease-Activated Receptor-1 Antagonist, Inhibits Thrombosis Alone and in Combination With Cangrelor in a Folts Model of Arterial Thrombosis in Cynomolgus Monkeys

Madhu Chintala, John Strony, Bo Yang et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2010 · 45 citations

Phosphoramidon does not inhibit endogenous endothelin-1 release stimulated by hemorrhage, cytokines and hypoxia in rats

Subbarao Vemulapalli, Peter J.S. Chiu, Kerry Griscti et al. · European Journal of Pharmacology · 1994 · 36 citations

Inflammation, Medicine, Physiology +7

Discovery of SCH 900271, a Potent Nicotinic Acid Receptor Agonist for the Treatment of Dyslipidemia

Anandan Palani, Ashwin U. Rao, Xiao Chen et al. · ACS Medicinal Chemistry Letters · 2011 · 27 citations · Full text

Sch 900271, Medicinal Chemistry, Lipid Disorder +15

Activation of central melanocortin receptors by MT‐II increases cavernosal pressure in rabbits by the neuronal release of NO

Rao Vemulapalli, Stan Kurowski, Brian Salisbury et al. · British Journal of Pharmacology · 2001 · 25 citations · Full text